Snowball logo
logo
3000

Shanghai Kaibao Pharmaceutical

300039 SHE
¥6.21¥0.00  (0%)
Estimate
P/E
24.8
EPS
0.25
Beta
0.268
Growth
Revenue, YoY
-29.3%
Net income, YoY
-23.05%
FCF, YoY
-44.98%
Dividends
Dividend yield
3.22%
Annual payout
¥0.20
Next ex. div date
November 29, 26
Payout
52.46%
Div.growth, 5y
5.39%
Dividend growth streak
4 y
Div.rating
About the company
Ticker
300039
ISIN
CNE100000JZ3
Country
China
Sector (GICS)
Healthcare
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and respiratory infections; and Phlegm-Heat Clearing Capsules to clear heat, resolve phlegm, and detoxifying. It also provides liver-protecting products, including Thiopronine for injection and Thiopronine enteric-coated tablets. In addition, the company provides Astragalus and Ginseng Capsules for the treatment of cardiovascular and cerebrovascular diseases. Further, it offers diclofenac sodium enteric-coated tablets; artificial bezoar metronidazole capsules; Mai'an granules; Loquat cough granules that clears the lungs, relieves cough, and reduces phlegm; compound danshen tablets; Tongmai granules to promote blood circulation and unblocks meridians; pediatric pharyngeal granules; stroke rejuvenation pills; and Xiao Chai Hu granules which relieves exterior syndromes, clears heat, soothes the liver, and harmonizes the stomach. Further, the company provides Alopecia areata; Bear bile drops that clears heat, calms the liver, and improves eyesight, as well as used for infantile convulsions and sore throat; and Shanhaidan capsules. Shanghai Kaibao Pharmaceutical CO.,Ltd was founded in 2000 and is based in Shanghai, China.

Frequently asked questions

What sector does Shanghai Kaibao Pharmaceutical (300039) operate in?

Shanghai Kaibao Pharmaceutical belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Shanghai Kaibao Pharmaceutical (300039) current stock price?

As of the latest data, Shanghai Kaibao Pharmaceutical stock price is CN¥6.21, with a previous close of CN¥6.21.

What is Shanghai Kaibao Pharmaceutical (300039) current market capitalization?

Shanghai Kaibao Pharmaceutical market cap is approximately 6.50 billion.

What is Shanghai Kaibao Pharmaceutical (300039) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.25.

What is Shanghai Kaibao Pharmaceutical (300039) Price-to-Earnings (P/E) ratio?

Shanghai Kaibao Pharmaceutical current P/E ratio is 24.84.

Does Shanghai Kaibao Pharmaceutical (300039) pay dividends?

Yes. Shanghai Kaibao Pharmaceutical pays semiannual dividends with an annualized yield of 3.22% and an estimated annual payout of CN¥0.20 per share.

When is the next ex-dividend date for Shanghai Kaibao Pharmaceutical (300039)?

The next ex-dividend date is scheduled for November 29, 2026.

What is Shanghai Kaibao Pharmaceutical (300039) beta (volatility) score?

Shanghai Kaibao Pharmaceutical has a beta of 0.268, indicating lower volatility than the overall market.